Tapentadol is partly metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medications that improve or repress the exercise/expression of a number of of those enzymes, and also with substrates of these enzymes (on account of Opposition with the enzyme); some enzyme mediators/substrates need https://franciszekj654pwd0.wikitidings.com/user